LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p
Breast Cancer: Targets and Therapy · 2026-04 · Volume 18 · 1-14
DOI: 10.2147/bctt.s596228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-04. Verfasst von Min Xiong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Affiliated Renhe Hospital of China Three Gorges University, Yichang, Hubei, 443000, People's Republic of China. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, Affiliated Renhe Hospital of China Three Gorges University, Yichang, Hubei, 443000, People's Republic of China.
Zitieren
APA
Xiong, M., Yang, Q., Cheng, L., Yu, L., & Hu, Y. (2026). LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p. Breast Cancer: Targets and Therapy, Volume 18, 1-14. https://doi.org/10.2147/bctt.s596228
Vancouver
Xiong M, Yang Q, Cheng L, Yu L, Hu Y. LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-14. doi:10.2147/bctt.s596228
BibTeX
@article{Xiong2026,
author = {Xiong, Min and Yang, Quanjun and Cheng, Le and Yu, Lili and Hu, Yili},
title = {LINC01128 Affects Triple-Negative Breast Cancer Progression Through Targeting miR-32-5p},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--14},
doi = {10.2147/bctt.s596228}
}
EUVIMED